Application of Artificial Intelligence to Address Issues Related to the COVID-19 Virus

Author:

Senthilraja M.1

Affiliation:

1. Department of Pharmaceutical Chemistry, J.K.K. Nattraja College of Pharmacy, Komarapalayam, Tamil Nadu, India

Abstract

Artificial intelligence (AI) plays a major role in addressing novel coronavirus 2019 (COVID-19)-related issues and is also used in computer-aided synthesis planning (CASP). AI, including machine learning, is used by artificial neural networks such as deep neural networks and recurrent networks. AI has been used in activity predictions like physicochemical properties. Machine learning in de novo design explores the generation of fruitful, biologically active molecules toward expected or finished products. Several examples establish the strength of machine learning or AI in this field. AI techniques can significantly improve treatment consistency and decision making by developing useful algorithms. AI is helpful not only in the treatment of COVID-19-infected patients but also for their proper health monitoring. It can track the crisis of COVID-19 at different scales, such as medical, molecular, and epidemiological applications. It is also helpful to facilitate the research on this virus by analyzing the available data. AI can help in developing proper treatment regimens, prevention strategies, and drug and vaccine development. Combination with synthesis planning and ease of synthesis are feasible, and more and more automated drug discovery by computers is expected in the near future to eradicate the COVID-19 virus.

Publisher

Elsevier BV

Subject

Medical Laboratory Technology,Computer Science Applications

Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3